Companies
Gnosis by Lesaffre
produces enriched nutritional yeasts positioned for beauty and mobility health applications, part of a broader specialty-yeast ingredient portfolio sold to supplement and food manufacturers.
- Country
- France
EU
Coverage
| EU | US | |
|---|---|---|
| food-alt-protein | ✓ | ✓ |
Regulatorsfdaefsa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | No funding | prospeo.io |
| Capacity | 120 tonnes of chondroïtine per year in phase one, increasing to 240 tonnes in phase two | registre-numerique.fr |
| Certification | GMP (Good Manufacturing Practice) certification | inventoryready.com · lesaffre.com.cn |
| Regulatory approval | Meets strict European and pharmaceutical standards | lesaffre.com.cn |
| Production site | Sant’Antonino, Switzerland and Pisticci, Italy | inventoryready.com · niemagazine.com |
| Production site | Denain, France (planned unit) medium confidence | registre-numerique.fr |
| Revenue | $150,000,000 annually | prospeo.io |
Independent sources: inventoryready.com · lesaffre.com.cn · niemagazine.com · prospeo.io · registre-numerique.fr
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Chelated mineral supplements from fermentation | food-alt-protein | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.